Sofindev

Sofindev Management NV is a private equity firm based in Diegem, Belgium, established in 1991. The firm specializes in investing in small and medium-sized enterprises in the Benelux region, focusing on buyouts and growth capital investments. Sofindev targets mature companies with enterprise values ranging from €10 million to €80 million and prefers to invest between €2 million and €20 million. The firm's investment strategy emphasizes value creation through professionalization and often involves taking a majority or significant minority stake in its portfolio companies. Sofindev invests across various sectors, including agriculture, chemicals, manufacturing, and financial services, while excluding the accommodation and catering industries. The firm typically exits investments within five to ten years through methods such as IPOs, trade sales, or secondary buyouts. With a stable base of reputable family and institutional investors, Sofindev is recognized for its long-term commitment to the Belgian market and its experienced investment team.

Jean-Roger de Bandt

Partner

Nicolas De Bruyne

Investment Director

Jan Camerlynck

Partner

Carlo Daelemans

Partner

Eric Van Droogenbroeck

Managing Partner

Lodewijk Koeman

Investment Partner

Starquit, Joëlle

CFO

Christophe Steverlinck

Principal

Vandewiele CFA, Sven

Investment Manager

Maurice van Veggel

Partner

7 past transactions

WVT Industries

Acquisition in 2019
WVT Industries specializes in industrial cleaning products tailored to the customer for various applications and various sectors.

House of Talents

Acquisition in 2016
House of Talents is a privately held company that provide Hr services for shortage occupations/strategic and financial support to organic and external growth.

GeoDynamics International

Acquisition in 2016
GeoDynamics is a privately held company that specialised in developing award winning location-based software solutions.

Gantner Ticketing

Acquisition in 2013
Gantner Ticketing has been providing ticketing and leisure management solutions for the arts and cultural sector.

Abelag

Acquisition in 2007
Abelag is a privately held company that operates fifteen business aircraft, both jets and turbo-props.

Topcom Europe

Venture Round in 2005
Topcom Europe NV develops, manufactures, and sells communication and lifecare products for residential and small office home office markets. The company's products include cordless and corded telephones, walkie-talkies, Internet telephones, voice over IP adapters and solutions, modems, wireless and wired networking, broadband and wireless LAN products, and accessories, as well as accessories for Internet communications. Its products also include handheld massage appliances, massage cushions, neck and spot massage appliances, and foot and leg massage appliances; wrist and arm blood pressure monitors, ear thermometers, nutrition scales, and body weight scales; sport watches, bicycle computers, chronographs, emergency led lights, and humidifiers; and fetal doppler monitors, babyphones, hygrometers, medical sets, baby bottle warmers, steamers, cookers, and toys. The company serves OEM customers. It sells its products through agents and distributors, electronics chains, discounters, retailers, computer shops, department stores, lifecare and baby care stores, and telecom specialists, as well as through electricians and operators in Europe, Asia, Australia, the Middle East, South Africa, and North and South America. The company was founded in 1991 and is based in Heverlee, Belgium with sales offices in Kungsbacka, Sweden; Madrid, Spain; Warszawa, Poland; Senkvice, Slovak Republic; Düsseldorf, Germany; and Hong Kong, Hong Kong. It has a branch office in Shenzhen, the People's Republic of China.

Hybrigenics

Series B in 2001
Hybrigenics Pharma is a bio-pharmaceutical company with a focus on research and development of new targets and therapies against cancer.Hybrigenics Pharma has stopped the development of inecalcitol, a vitamin D receptor agonist.Hybrigenics Pharma's research program investigates the action of enzymes called Deubiquitinating Enzymes (DUBs) in the recycling of onco-proteins and the potential activity of proprietary patented DUB inhibitors against various cancer indications.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.